ImmunoGen

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGN, HA, CERE, HOLI

Retrieved on: 
Monday, January 1, 2024
Advertising, Hawaiian Airlines, Fraud, Sale, ImmunoGen, AbbVie, Security (finance)

If you are an ImmunoGen shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an ImmunoGen shareholder, click here to learn more about your rights and options .
  • If you are a Hawaiian shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, BVH, IMGN

Retrieved on: 
Wednesday, December 27, 2023
Sale, Eargo, Realty Income, ImmunoGen, Fraud, AbbVie, Advertising, Blue-green, Security (finance)

If you are a Spirit Realty shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Spirit Realty shareholder, click here to learn more about your rights and options .
  • If you are an Eargo shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER ALERT: Juan Monteverde Encourages the Shareholders of ICVX, EAR, CVLY, IMGN to Take Action

Retrieved on: 
Wednesday, December 27, 2023
Empire, CVR, IMGN, AstraZeneca, Sale, Monteverde, EAR, ImmunoGen, AbbVie, Eargo, Security (finance)

Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.

Key Points: 
  • Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.
  • Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
  • Under the terms of the agreement, CVLY shareholders are expected to own approximately 44% of the outstanding shares of the combined company.
  • Under the terms of the agreement, IMGN shareholders will receive $31.26 in cash per share they own.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGN, HA, EAR

Retrieved on: 
Thursday, December 14, 2023
Advertising, Hawaiian Airlines, Eargo, Fraud, Sale, ImmunoGen, AbbVie, Security (finance)

If you are an ImmunoGen shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an ImmunoGen shareholder, click here to learn more about your rights and options .
  • If you are a Hawaiian shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – EAR, IMGN, CVLY, EVFM

Retrieved on: 
Thursday, December 14, 2023
Empire, IMGN, Sale, Monteverde, EAR, ImmunoGen, AbbVie, OTC, Eargo, Security (finance)

Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
  • Under the terms of the agreement, IMGN shareholders will receive $31.26 in cash per share they own.
  • Under the terms of the agreement, CVLY shareholders are expected to own approximately 44% of the outstanding shares of the combined company.
  • Evofem Biosciences, Inc. (OTC: EVFM ), relating to its proposed sale to Aditxt, Inc. Click here for more information: https://www.monteverdelaw.com/case/evofem-biosciences-inc .

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (

Retrieved on: 
Monday, December 11, 2023
Graphite, Brodsky, Consolidated, Agreement, Searchlight Capital, Therapy, AbbVie, ImmunoGen, ABBV, Consolidated Communications, Crown corporations of Canada, Security (finance)

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Agreement, Buyers will acquire all of the Consolidated common stock not already owned by Searchlight for $4.70 per share in cash.
  • Under the terms of the Merger Agreement, Cerevel will be acquired by AbbVie Inc. (NYSE - ABBV).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HA, PFIN, IMGN, SP

Retrieved on: 
Saturday, December 9, 2023
Hawaiian Airlines, Sale, ImmunoGen, Fraud, AbbVie, Advertising, Security (finance)

If you are a Hawaiian shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Hawaiian shareholder, click here to learn more about your rights and options .
  • If you are a P&F shareholder, click here to learn more about your rights and options .
  • If you are a SP® Plus shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SRC, IMGN, PATI, ROVR

Retrieved on: 
Tuesday, December 5, 2023
Patriot Transportation, Empire, Blackstone Inc., SRC, IMGN, Sale, Monteverde, ImmunoGen, Rover Group, RIC, AbbVie, Security (finance)

Under the terms of the agreement, SRC shareholders will receive 0.762 shares of RIC per share they own.

Key Points: 
  • Under the terms of the agreement, SRC shareholders will receive 0.762 shares of RIC per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, IMGN shareholders will receive $31.26 in cash per share they own.
  • Under the terms of the agreement, ROVR shareholders will receive $11.00 in cash pers share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

Retrieved on: 
Monday, December 4, 2023
Graphite, ALK, Alaska Air Group, Brodsky, Atmosphere of Earth, Nitenpyram, Therapy, ImmunoGen, AbbVie, ABBV, Old, Old National Bank, Alaska Airlines, Security (finance)

BALA CYNWYD, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Hawaiian Airlines will be acquired by Alaska Air Group, Inc. (NYSE - ALK).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of ImmunoGen

Retrieved on: 
Thursday, November 30, 2023
LLP, Sale, ImmunoGen, Learning, AbbVie, SAN, IMGN

SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ImmunoGen, Inc. (NASDAQ: IMGN) breached their fiduciary duties in connection with the proposed sale of the Company to AbbVie.

Key Points: 
  • SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ImmunoGen, Inc. (NASDAQ: IMGN) breached their fiduciary duties in connection with the proposed sale of the Company to AbbVie.
  • You can click or copy and paste the following link to join this investigation:
    On November 30, 2023, ImmunoGen announced that it had entered a deal to merge with AbbVie.
  • Under the terms of the deal, ImmunoGen shareholders will receive $31.26 per share in cash.
  • If you are a shareholder of ImmunoGen and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker ( [email protected] ) at 619-814-4471.